Healthcare -
Biotechnology - NASDAQ - US
$ 8.54
0 %
$ 801 M
Market Cap
-8.63
P/E
CASH FLOW STATEMENT
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Chimerix, Inc.
| Net Income | -88.4 M |
| Depreciation & Amortization | 94 K |
| Capital Expenditures | -287 K |
| Stock-Based Compensation | 9.48 M |
| Change in Working Capital | 7.44 M |
| Others | -1.61 M |
| Free Cash Flow | -75.3 M |
Cash Flow
Millions
| Dec-2024 | Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Dec-2014 | Dec-2013 | Dec-2012 | Dec-2011 | Dec-2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | |||||||||||||||
| Net Income | (88.4) | (82.1) | 172.2 | (173.2) | (43.5) | (112.6) | (69.5) | (71.0) | (76.4) | (117.4) | (59.3) | (36.4) | (4.4) | (25.6) | (25.5) |
| Depreciation & Amortization | 94 K | 1 K | 98 K | 0.2 | 0.4 | 0.6 | 0.9 | 1.1 | 1.1 | 0.7 | 0.3 | 0.3 | 0.3 | 0.3 | 0.2 |
| Deferred Income Tax | 0 | 0 | 0 | 0.8 | (0.2) | (1.5) | (0.1) | 1.2 | 1.2 | 1.6 | 1.2 | 6.8 | 0.9 | 0.5 | 0.1 |
| Stock Based Compensation | 9.5 | 17.5 | 15.3 | 12.3 | 5.6 | 9.5 | 13.1 | 16.1 | 16.2 | 13.0 | 4.4 | 3.1 | 1.4 | 1.1 | 0.8 |
| Other Operating Activities | (3.6) | (6.9) | (231.0) | 57.7 | 14 K | 34.8 | 59 K | (0.3) | 0.1 | 83 K | 0.1 | 0.3 | 0.2 | 46 K | 19 K |
| Change in Working Capital | 7.4 | 2.4 | (3.4) | 2.3 | 1.7 | (6.0) | 2.0 | 2.8 | (6.1) | 2.2 | 6.2 | 0.5 | (0.3) | (2.6) | 2.7 |
| Cash From Operations | (75.0) | (69.1) | (46.9) | (99.9) | (36.0) | (75.2) | (53.7) | (50.1) | (63.8) | (99.9) | (47.1) | (25.6) | (1.9) | (26.3) | (21.7) |
| INVESTING CASH FLOW | |||||||||||||||
| Capital Expenditures | (0.3) | 89 K | 71 K | (0.2) | 58 K | (0.2) | (0.2) | (0.2) | (0.8) | (2.2) | (1.0) | (0.2) | (0.1) | (0.3) | (0.1) |
| Other Items | 71.6 | 70.7 | 70.1 | (43.9) | 64.8 | 10.8 | 105.3 | 16.6 | 94.9 | (167.1) | (158.7) | 9.7 | (4.0) | (5.9) | (0.1) |
| Cash From Investing Activities | 71.3 | 70.6 | 70.0 | (44.1) | 64.7 | 10.6 | 105.1 | 16.4 | 94.1 | (169.3) | (159.7) | 9.5 | (4.1) | (6.2) | (0.2) |
| FINANCING CASH FLOW | |||||||||||||||
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Debt Repaid | 0 | 0 | (14.0) | 0 | 0 | 0 | 0 | 0 | 0 | (4.3) | (5.7) | (5.0) | 12.4 | (2.0) | 4.6 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0.2 | 0.3 | (0.2) | 4.6 | 1.4 | 0.3 | 0.3 | 0.8 | 0.6 | 3.8 | 5.0 | 3.5 | 85 K | 44.8 | 37 K |
| Cash From Financing Activities | 7.0 | 0.3 | (12.7) | 112.4 | 1.4 | 0.3 | 11.2 | 0.8 | 0.6 | 161.3 | 225.3 | 106.2 | 12.3 | 42.8 | 4.6 |
| CHANGE IN CASH | |||||||||||||||
| Net Change In Cash | 3.4 | 1.8 | 10.4 | (31.6) | 30.1 | (64.2) | 62.6 | (32.9) | 30.9 | (107.9) | 18.5 | 90.1 | 6.3 | 10.3 | (17.3) |
| FREE CASH FLOW | |||||||||||||||
| Free Cash Flow | (75.3) | (69.2) | (46.9) | (100.1) | (36.1) | (75.3) | (53.9) | (50.3) | (64.7) | (102.1) | (48.1) | (25.8) | (2.0) | (26.6) | (21.8) |